Global Generic Drugs Sales Market Report 2023

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drugs Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Prescription
1.2.3 Non-Prescription Drugs
1.3 Market by Application
1.3.1 Global Generic Drugs Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Drugs Market Perspective (2018-2029)
2.2 Global Generic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Generic Drugs Revenue Market Share by Region (2018-2023)
2.4 Global Generic Drugs Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Generic Drugs Estimates and Projections (2018-2029)
2.5.2 Europe Generic Drugs Estimates and Projections (2018-2029)
2.5.3 China Generic Drugs Estimates and Projections (2018-2029)
2.5.4 Japan Generic Drugs Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Generic Drugs Estimates and Projections (2018-2029)
2.5.6 India Generic Drugs Estimates and Projections (2018-2029)
3 Global Generic Drugs Competition Landscape by Players
3.1 Global Top Generic Drugs Players by Revenue (2018-2023)
3.1.1 Global Top Generic Drugs Players by Revenue (2018-2023)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Generic Drugs Revenue
3.4 Global Generic Drugs Market Concentration Ratio
3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2022
3.5 Generic Drugs Key Players Head office and Area Served
3.6 Key Players Generic Drugs Product Solution and Service
3.7 Date of Enter into Generic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drugs Breakdown Data by Type
4.1 Global Generic Drugs Historic Market Size by Type (2018-2023)
4.2 Global Generic Drugs Forecasted Market Size by Type (2024-2029)
5 Generic Drugs Breakdown Data by Application
5.1 Global Generic Drugs Historic Market Size by Application (2018-2023)
5.2 Global Generic Drugs Forecasted Market Size by Application (2024-2029)
6 United States Generic Drugs Market Facts & Figures
6.1 United States Generic Drugs Revenue by Company (2018-2023)
6.2 United States Generic Drugs Market Size by Type
6.2.1 United States Generic Drugs Market Size by Type (2018-2023)
6.2.2 United States Generic Drugs Market Size by Type (2024-2029)
6.2.3 United States Generic Drugs Market Share by Type (2018-2029)
6.3 United States Generic Drugs Market Size by Application
6.3.1 United States Generic Drugs Market Size by Application (2018-2023)
6.3.2 United States Generic Drugs Market Size by Application (2024-2029)
6.3.3 United States Generic Drugs Market Share by Application (2018-2029)
7 Europe Generic Drugs Market Facts & Figures
7.1 Europe Generic Drugs Revenue by Company (2018-2023)
7.2 Europe Generic Drugs Market Size by Type
7.2.1 Europe Generic Drugs Market Size by Type (2018-2023)
7.2.2 Europe Generic Drugs Market Size by Type (2024-2029)
7.2.3 Europe Generic Drugs Market Share by Type (2018-2029)
7.3 Europe Generic Drugs Market Size by Application
7.3.1 Europe Generic Drugs Market Size by Application (2018-2023)
7.3.2 Europe Generic Drugs Market Size by Application (2024-2029)
7.3.3 Europe Generic Drugs Market Share by Application (2018-2029)
8 China Generic Drugs Market Facts & Figures
8.1 China Generic Drugs Revenue by Company (2018-2023)
8.2 China Generic Drugs Market Size by Type
8.2.1 China Generic Drugs Market Size by Type (2018-2023)
8.2.2 China Generic Drugs Market Size by Type (2024-2029)
8.2.3 China Generic Drugs Market Share by Type (2018-2029)
8.3 China Generic Drugs Market Size by Application
8.3.1 China Generic Drugs Market Size by Application (2018-2023)
8.3.2 China Generic Drugs Market Size by Application (2024-2029)
8.3.3 China Generic Drugs Market Share by Application (2018-2029)
9 Japan Generic Drugs Market Facts & Figures
9.1 Japan Generic Drugs Revenue by Company (2018-2023)
9.2 Japan Generic Drugs Market Size by Type
9.2.1 Japan Generic Drugs Market Size by Type (2018-2023)
9.2.2 Japan Generic Drugs Market Size by Type (2024-2029)
9.2.3 Japan Generic Drugs Market Share by Type (2018-2029)
9.3 Japan Generic Drugs Market Size by Application
9.3.1 Japan Generic Drugs Market Size by Application (2018-2023)
9.3.2 Japan Generic Drugs Market Size by Application (2024-2029)
9.3.3 Japan Generic Drugs Market Share by Application (2018-2029)
10 Southeast Asia Generic Drugs Market Facts & Figures
10.1 Southeast Asia Generic Drugs Revenue by Company (2018-2023)
10.2 Southeast Asia Generic Drugs Market Size by Type
10.2.1 Southeast Asia Generic Drugs Market Size by Type (2018-2023)
10.2.2 Southeast Asia Generic Drugs Market Size by Type (2024-2029)
10.2.3 Southeast Asia Generic Drugs Market Share by Type (2018-2029)
10.3 Southeast Asia Generic Drugs Market Size by Application
10.3.1 Southeast Asia Generic Drugs Market Size by Application (2018-2023)
10.3.2 Southeast Asia Generic Drugs Market Size by Application (2024-2029)
10.3.3 Southeast Asia Generic Drugs Market Share by Application (2018-2029)
11 India Generic Drugs Market Facts & Figures
11.1 India Generic Drugs Revenue by Company (2018-2023)
11.2 India Generic Drugs Market Size by Type
11.2.1 India Generic Drugs Market Size by Type (2018-2023)
11.2.2 India Generic Drugs Market Size by Type (2024-2029)
11.2.3 India Generic Drugs Market Share by Type (2018-2029)
11.3 India Generic Drugs Market Size by Application
11.3.1 India Generic Drugs Market Size by Application (2018-2023)
11.3.2 India Generic Drugs Market Size by Application (2024-2029)
11.3.3 India Generic Drugs Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 Teva
12.1.1 Teva Company Details
12.1.2 Teva Business Overview
12.1.3 Teva Generic Drugs Introduction
12.1.4 Teva Revenue in Generic Drugs Business (2018-2023)
12.1.5 Teva Recent Development
12.2 Novartis - Sandoz
12.2.1 Novartis - Sandoz Company Details
12.2.2 Novartis - Sandoz Business Overview
12.2.3 Novartis - Sandoz Generic Drugs Introduction
12.2.4 Novartis - Sandoz Revenue in Generic Drugs Business (2018-2023)
12.2.5 Novartis - Sandoz Recent Development
12.3 Mylan
12.3.1 Mylan Company Details
12.3.2 Mylan Business Overview
12.3.3 Mylan Generic Drugs Introduction
12.3.4 Mylan Revenue in Generic Drugs Business (2018-2023)
12.3.5 Mylan Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Details
12.4.2 Sun Pharmaceutical Business Overview
12.4.3 Sun Pharmaceutical Generic Drugs Introduction
12.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2023)
12.4.5 Sun Pharmaceutical Recent Development
12.5 Aspen
12.5.1 Aspen Company Details
12.5.2 Aspen Business Overview
12.5.3 Aspen Generic Drugs Introduction
12.5.4 Aspen Revenue in Generic Drugs Business (2018-2023)
12.5.5 Aspen Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Company Details
12.6.2 Fresenius Kabi Business Overview
12.6.3 Fresenius Kabi Generic Drugs Introduction
12.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2018-2023)
12.6.5 Fresenius Kabi Recent Development
12.7 Pfizer (Hospira)
12.7.1 Pfizer (Hospira) Company Details
12.7.2 Pfizer (Hospira) Business Overview
12.7.3 Pfizer (Hospira) Generic Drugs Introduction
12.7.4 Pfizer (Hospira) Revenue in Generic Drugs Business (2018-2023)
12.7.5 Pfizer (Hospira) Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Sanofi Business Overview
12.8.3 Sanofi Generic Drugs Introduction
12.8.4 Sanofi Revenue in Generic Drugs Business (2018-2023)
12.8.5 Sanofi Recent Development
12.9 Aurobindo
12.9.1 Aurobindo Company Details
12.9.2 Aurobindo Business Overview
12.9.3 Aurobindo Generic Drugs Introduction
12.9.4 Aurobindo Revenue in Generic Drugs Business (2018-2023)
12.9.5 Aurobindo Recent Development
12.10 Lupin
12.10.1 Lupin Company Details
12.10.2 Lupin Business Overview
12.10.3 Lupin Generic Drugs Introduction
12.10.4 Lupin Revenue in Generic Drugs Business (2018-2023)
12.10.5 Lupin Recent Development
12.11 Dr. Reddy's
12.11.1 Dr. Reddy's Company Details
12.11.2 Dr. Reddy's Business Overview
12.11.3 Dr. Reddy's Generic Drugs Introduction
12.11.4 Dr. Reddy's Revenue in Generic Drugs Business (2018-2023)
12.11.5 Dr. Reddy's Recent Development
12.12 Apotex
12.12.1 Apotex Company Details
12.12.2 Apotex Business Overview
12.12.3 Apotex Generic Drugs Introduction
12.12.4 Apotex Revenue in Generic Drugs Business (2018-2023)
12.12.5 Apotex Recent Development
12.13 Cipla
12.13.1 Cipla Company Details
12.13.2 Cipla Business Overview
12.13.3 Cipla Generic Drugs Introduction
12.13.4 Cipla Revenue in Generic Drugs Business (2018-2023)
12.13.5 Cipla Recent Development
12.14 ENDO (Par Pharmaceutical)
12.14.1 ENDO (Par Pharmaceutical) Company Details
12.14.2 ENDO (Par Pharmaceutical) Business Overview
12.14.3 ENDO (Par Pharmaceutical) Generic Drugs Introduction
12.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2018-2023)
12.14.5 ENDO (Par Pharmaceutical) Recent Development
12.15 Stada Arzneimittel
12.15.1 Stada Arzneimittel Company Details
12.15.2 Stada Arzneimittel Business Overview
12.15.3 Stada Arzneimittel Generic Drugs Introduction
12.15.4 Stada Arzneimittel Revenue in Generic Drugs Business (2018-2023)
12.15.5 Stada Arzneimittel Recent Development
12.16 Krka Group
12.16.1 Krka Group Company Details
12.16.2 Krka Group Business Overview
12.16.3 Krka Group Generic Drugs Introduction
12.16.4 Krka Group Revenue in Generic Drugs Business (2018-2023)
12.16.5 Krka Group Recent Development
12.17 Nichi-Iko Pharmaceutical
12.17.1 Nichi-Iko Pharmaceutical Company Details
12.17.2 Nichi-Iko Pharmaceutical Business Overview
12.17.3 Nichi-Iko Pharmaceutical Generic Drugs Introduction
12.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2018-2023)
12.17.5 Nichi-Iko Pharmaceutical Recent Development
12.18 Valeant
12.18.1 Valeant Company Details
12.18.2 Valeant Business Overview
12.18.3 Valeant Generic Drugs Introduction
12.18.4 Valeant Revenue in Generic Drugs Business (2018-2023)
12.18.5 Valeant Recent Development
12.19 Zydus Cadila
12.19.1 Zydus Cadila Company Details
12.19.2 Zydus Cadila Business Overview
12.19.3 Zydus Cadila Generic Drugs Introduction
12.19.4 Zydus Cadila Revenue in Generic Drugs Business (2018-2023)
12.19.5 Zydus Cadila Recent Development
12.20 Hikma
12.20.1 Hikma Company Details
12.20.2 Hikma Business Overview
12.20.3 Hikma Generic Drugs Introduction
12.20.4 Hikma Revenue in Generic Drugs Business (2018-2023)
12.20.5 Hikma Recent Development
12.21 Pharmaniaga Berhad
12.21.1 Pharmaniaga Berhad Company Details
12.21.2 Pharmaniaga Berhad Business Overview
12.21.3 Pharmaniaga Berhad Generic Drugs Introduction
12.21.4 Pharmaniaga Berhad Revenue in Generic Drugs Business (2018-2023)
12.21.5 Pharmaniaga Berhad Recent Development
12.22 Hovid Berhad
12.22.1 Hovid Berhad Company Details
12.22.2 Hovid Berhad Business Overview
12.22.3 Hovid Berhad Generic Drugs Introduction
12.22.4 Hovid Berhad Revenue in Generic Drugs Business (2018-2023)
12.22.5 Hovid Berhad Recent Development
12.23 Duopharma Biotech
12.23.1 Duopharma Biotech Company Details
12.23.2 Duopharma Biotech Business Overview
12.23.3 Duopharma Biotech Generic Drugs Introduction
12.23.4 Duopharma Biotech Revenue in Generic Drugs Business (2018-2023)
12.23.5 Duopharma Biotech Recent Development
12.24 Kotra Pharma
12.24.1 Kotra Pharma Company Details
12.24.2 Kotra Pharma Business Overview
12.24.3 Kotra Pharma Generic Drugs Introduction
12.24.4 Kotra Pharma Revenue in Generic Drugs Business (2018-2023)
12.24.5 Kotra Pharma Recent Development
12.25 HOE Pharmaceutical
12.25.1 HOE Pharmaceutical Company Details
12.25.2 HOE Pharmaceutical Business Overview
12.25.3 HOE Pharmaceutical Generic Drugs Introduction
12.25.4 HOE Pharmaceutical Revenue in Generic Drugs Business (2018-2023)
12.25.5 HOE Pharmaceutical Recent Development
12.26 Y.S.P. Industries
12.26.1 Y.S.P. Industries Company Details
12.26.2 Y.S.P. Industries Business Overview
12.26.3 Y.S.P. Industries Generic Drugs Introduction
12.26.4 Y.S.P. Industries Revenue in Generic Drugs Business (2018-2023)
12.26.5 Y.S.P. Industries Recent Development
13 Market Dynamics
13.1 Generic Drugs Industry Trends
13.2 Generic Drugs Market Drivers
13.3 Generic Drugs Market Challenges
13.4 Generic Drugs Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer

List of Tables
Table 1. Global Generic Drugs Market Size Growth Rate by Type (US$ Million): (2018 VS 2022 VS 2029)
Table 2. Major Players of Prescription
Table 3. Major Players of Non-Prescription Drugs
Table 4. Global Generic Drugs Market Size Growth by Application (2018 VS 2022 VS 2029)
Table 5. Global Generic Drugs Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 6. Global Generic Drugs Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Generic Drugs Revenue Share by Region (2018-2023)
Table 8. Global Generic Drugs Revenue (US$ Million) Forecast by Region (2024-2029)
Table 9. Global Generic Drugs Revenue Share Forecast by Region (2024-2029)
Table 10. Global Generic Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global Generic Drugs Revenue Share by Players (2018-2023)
Table 12. Global Generic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Drugs as of 2022)
Table 13. Ranking of Global Top Generic Drugs Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Generic Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Generic Drugs Product Solution and Service
Table 17. Date of Enter into Generic Drugs Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global Generic Drugs Revenue Market Share by Type (2018-2023)
Table 21. Global Generic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 22. Global Generic Drugs Revenue Market Share by Type (2024-2029)
Table 23. Global Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global Generic Drugs Revenue Market Share by Application (2018-2023)
Table 25. Global Generic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 26. Global Generic Drugs Revenue Market Share by Application (2024-2029)
Table 27. United States Generic Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 28. United States Generic Drugs Revenue Market Share by Company (2018-2023)
Table 29. United States Generic Drugs Market Size by Type (2018-2023) & (K MT)
Table 30. United States Generic Drugs Market Size by Type (2024-2029) & (K MT)
Table 31. United States Generic Drugs Market Size by Application (2018-2023) & (K MT)
Table 32. United States Generic Drugs Market Size by Application (2024-2029) & (K MT)
Table 33. Europe Generic Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 34. Europe Generic Drugs Revenue Market Share by Company (2018-2023)
Table 35. Europe Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 36. Europe Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 37. Europe Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 38. Europe Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 39. China Generic Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 40. China Generic Drugs Revenue Market Share by Company (2018-2023)
Table 41. China Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. China Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 43. China Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. China Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 45. Japan Generic Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 46. Japan Generic Drugs Revenue Market Share by Company (2018-2023)
Table 47. Japan Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 48. Japan Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 49. Japan Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 50. Japan Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 51. Southeast Asia Generic Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 52. Southeast Asia Generic Drugs Revenue Market Share by Company (2018-2023)
Table 53. Southeast Asia Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 54. Southeast Asia Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 55. Southeast Asia Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 56. Southeast Asia Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 57. India Generic Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 58. India Generic Drugs Revenue Market Share by Company (2018-2023)
Table 59. India Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. India Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 61. India Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. India Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 63. Teva Company Details
Table 64. Teva Description and Business Overview
Table 65. Teva Generic Drugs Product
Table 66. Teva Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 67. Teva Recent Development
Table 68. Novartis - Sandoz Company Details
Table 69. Novartis - Sandoz Description and Business Overview
Table 70. Novartis - Sandoz Generic Drugs Product
Table 71. Novartis - Sandoz Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 72. Novartis - Sandoz Recent Development
Table 73. Mylan Company Details
Table 74. Mylan Description and Business Overview
Table 75. Mylan Generic Drugs Product
Table 76. Mylan Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 77. Mylan Recent Development
Table 78. Sun Pharmaceutical Company Details
Table 79. Sun Pharmaceutical Description and Business Overview
Table 80. Sun Pharmaceutical Generic Drugs Product
Table 81. Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 82. Sun Pharmaceutical Recent Development
Table 83. Aspen Company Details
Table 84. Aspen Description and Business Overview
Table 85. Aspen Generic Drugs Product
Table 86. Aspen Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 87. Aspen Recent Development
Table 88. Fresenius Kabi Company Details
Table 89. Fresenius Kabi Description and Business Overview
Table 90. Fresenius Kabi Generic Drugs Product
Table 91. Fresenius Kabi Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 92. Fresenius Kabi Recent Development
Table 93. Pfizer (Hospira) Company Details
Table 94. Pfizer (Hospira) Description and Business Overview
Table 95. Pfizer (Hospira) Generic Drugs Product
Table 96. Pfizer (Hospira) Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 97. Pfizer (Hospira) Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Generic Drugs Product
Table 100. Sanofi Description and Business Overview
Table 101. Sanofi Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Aurobindo Company Details
Table 104. Aurobindo Generic Drugs Product
Table 105. Aurobindo Description and Business Overview
Table 106. Aurobindo Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 107. Aurobindo Recent Development
Table 108. Lupin Company Details
Table 109. Lupin Description and Business Overview
Table 110. Lupin Generic Drugs Product
Table 111. Lupin Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 112. Lupin Recent Development
Table 113. Dr. Reddy's Company Details
Table 114. Dr. Reddy's Description and Business Overview
Table 115. Dr. Reddy's Generic Drugs Product
Table 116. Dr. Reddy's Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 117. Dr. Reddy's Recent Development
Table 118. Apotex Company Details
Table 119. Apotex Description and Business Overview
Table 120. Apotex Generic Drugs Product
Table 121. Apotex Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 122. Apotex Recent Development
Table 123. Cipla Company Details
Table 124. Cipla Description and Business Overview
Table 125. Cipla Generic Drugs Product
Table 126. Cipla Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 127. Cipla Recent Development
Table 128. ENDO (Par Pharmaceutical) Company Details
Table 129. ENDO (Par Pharmaceutical) Description and Business Overview
Table 130. ENDO (Par Pharmaceutical) Generic Drugs Product
Table 131. ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 132. ENDO (Par Pharmaceutical) Recent Development
Table 133. Stada Arzneimittel Company Details
Table 134. Stada Arzneimittel Description and Business Overview
Table 135. Stada Arzneimittel Generic Drugs Product
Table 136. Stada Arzneimittel Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 137. Stada Arzneimittel Recent Development
Table 138. Krka Group Company Details
Table 139. Krka Group Description and Business Overview
Table 140. Krka Group Generic Drugs Product
Table 141. Krka Group Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 142. Krka Group Recent Development
Table 143. Nichi-Iko Pharmaceutical Company Details
Table 144. Nichi-Iko Pharmaceutical Description and Business Overview
Table 145. Nichi-Iko Pharmaceutical Generic Drugs Product
Table 146. Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 147. Nichi-Iko Pharmaceutical Recent Development
Table 148. Valeant Company Details
Table 149. Valeant Description and Business Overview
Table 150. Valeant Generic Drugs Product
Table 151. Valeant Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 152. Valeant Recent Development
Table 153. Zydus Cadila Company Details
Table 154. Zydus Cadila Description and Business Overview
Table 155. Zydus Cadila Generic Drugs Product
Table 156. Zydus Cadila Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 157. Zydus Cadila Recent Development
Table 158. Hikma Company Details
Table 159. Hikma Description and Business Overview
Table 160. Hikma Generic Drugs Product
Table 161. Hikma Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 162. Hikma Recent Development
Table 163. Pharmaniaga Berhad Company Details
Table 164. Pharmaniaga Berhad Description and Business Overview
Table 165. Pharmaniaga Berhad Generic Drugs Product
Table 166. Pharmaniaga Berhad Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 167. Pharmaniaga Berhad Recent Development
Table 168. Hovid Berhad Company Details
Table 169. Hovid Berhad Description and Business Overview
Table 170. Hovid Berhad Generic Drugs Product
Table 171. Hovid Berhad Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 172. Hovid Berhad Recent Development
Table 173. Duopharma Biotech Company Details
Table 174. Duopharma Biotech Description and Business Overview
Table 175. Duopharma Biotech Generic Drugs Product
Table 176. Duopharma Biotech Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 177. Duopharma Biotech Recent Development
Table 178. Kotra Pharma Company Details
Table 179. Kotra Pharma Description and Business Overview
Table 180. Kotra Pharma Generic Drugs Product
Table 181. Kotra Pharma Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 182. Kotra Pharma Recent Development
Table 183. HOE Pharmaceutical Company Details
Table 184. HOE Pharmaceutical Description and Business Overview
Table 185. HOE Pharmaceutical Generic Drugs Product
Table 186. HOE Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 187. HOE Pharmaceutical Recent Development
Table 188. Y.S.P. Industries Company Details
Table 189. Y.S.P. Industries Description and Business Overview
Table 190. Y.S.P. Industries Generic Drugs Product
Table 191. Y.S.P. Industries Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
Table 192. Y.S.P. Industries Recent Development
Table 193. Generic Drugs Market Trends
Table 194. Generic Drugs Market Drivers
Table 195. Generic Drugs Market Challenges
Table 196. Generic Drugs Market Restraints
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Drugs Market Share by Type: 2022 VS 2029
Figure 2. Prescription Features
Figure 3. Non-Prescription Drugs Features
Figure 4. Global Generic Drugs Market Share by Application: 2022 VS 2029
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Generic Drugs Report Years Considered
Figure 9. Global Generic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 10. Global Generic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Generic Drugs Revenue Market Share by Region: 2018 VS 2022
Figure 12. United States Generic Drugs Revenue (Million USD) Growth Rate (2018-2029)
Figure 13. Europe Generic Drugs Revenue (Million USD) Growth Rate (2018-2029)
Figure 14. China Generic Drugs Revenue (Million USD) Growth Rate (2018-2029)
Figure 15. Japan Generic Drugs Revenue (Million USD) Growth Rate (2018-2029)
Figure 16. Southeast Asia Generic Drugs Revenue (Million USD) Growth Rate (2018-2029)
Figure 17. India Generic Drugs Revenue (Million USD) Growth Rate (2018-2029)
Figure 18. Global Generic Drugs Market Share by Players in 2022
Figure 19. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Generic Drugs Revenue in 2022
Figure 21. United States Generic Drugs Market Share by Type (2018-2029)
Figure 22. United States Generic Drugs Market Share by Application (2018-2029)
Figure 23. Europe Generic Drugs Market Share by Type (2018-2029)
Figure 24. Europe Generic Drugs Market Share by Application (2018-2029)
Figure 25. China Generic Drugs Market Share by Type (2018-2029)
Figure 26. China Generic Drugs Market Share by Application (2018-2029)
Figure 27. Japan Generic Drugs Market Share by Type (2018-2029)
Figure 28. Japan Generic Drugs Market Share by Application (2018-2029)
Figure 29. Southeast Asia Generic Drugs Market Share by Type (2018-2029)
Figure 30. Southeast Asia Generic Drugs Market Share by Application (2018-2029)
Figure 31. India Generic Drugs Market Share by Type (2018-2029)
Figure 32. India Generic Drugs Market Share by Application (2018-2029)
Figure 33. Teva Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 34. Novartis - Sandoz Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 35. Mylan Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 36. Sun Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 37. Aspen Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 38. Fresenius Kabi Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 39. Pfizer (Hospira) Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 40. Sanofi Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 41. Aurobindo Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 42. Lupin Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 43. Dr. Reddy's Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 44. Apotex Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 45. Cipla Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 46. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 47. Stada Arzneimittel Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 48. Krka Group Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 49. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 50. Valeant Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 51. Zydus Cadila Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 52. Hikma Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 53. Pharmaniaga Berhad Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 54. Hovid Berhad Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 55. Duopharma Biotech Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 56. Kotra Pharma Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 57. HOE Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)
Figure 58. Y.S.P. Industries Revenue Growth Rate in Generic Drugs Business (2018-2023)
Fi